11 – 20 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function : Post hoc analyses of the EURIDIS-ADONIS trials
- Contribution to journal › Article
-
Mark
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction : a post-hoc analysis of the ATHENA trial
- Contribution to journal › Article
- 2021
-
Mark
Evaluating the Risk of Digitalis Intoxication Associated With Concomitant Use of Dronedarone and Digoxin Using Real-World Data
- Contribution to journal › Article
-
Mark
Amino acids predict prognosis in patients with acute dyspnea
- Contribution to journal › Article
-
Mark
Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database)
- Contribution to journal › Article
- 2020
-
Mark
Efficacy and safety of dronedarone by atrial fibrillation history duration : Insights from the ATHENA study
- Contribution to journal › Article
-
Mark
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter : A post hoc analysis of the EURIDIS and ADONIS trials
- Contribution to journal › Article
-
Mark
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter : Insights from the ATHENA study
- Contribution to journal › Article
- 2017
-
Mark
Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves : A Swedish cohort study
- Contribution to journal › Article
- 2016
-
Mark
Inflammatory biomarkers predicting prognosis in patients with acute dyspnea.
- Contribution to journal › Article
